(Q24806904)

English

Withdrawal of cerivastatin from the world market

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Withdrawal of cerivastatin from the world market (English)

0 references

2

Bertram Pitt

0 references

Curt Furberg

series ordinal

1

object named as

Curt D Furberg

0 references

language of work or name

1 reference

2001

0 references

published in

Current controlled trials in cardiovascular medicine

1 reference

stated in

PubMed

volume

2

0 references

issue

5

0 references

page(s)

205-207

0 references

cites work

The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59524

retrieved

7 April 2017

Debate: The slippery slope of surrogate outcomes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59524

retrieved

7 April 2017

Bayer faces potential fine over cholesterol lowering drug

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59524

retrieved

7 April 2017

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59524

retrieved

7 April 2017

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59524

retrieved

7 April 2017

Natural statins and stroke risk.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59524

retrieved

28 November 2018

Identifiers

DOI

10.1186/CVM-2-5-205

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2274474

Dimensions Publication ID

1015979413

0 references

OpenCitations bibliographic resource ID

2274474

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2274474

PubMed publication ID

11806796

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2274474

ResearchGate publication ID

11552029

0 references

(Q24806904)

Withdrawal of cerivastatin from the world market

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)